GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Change In Payables And Accrued Expense

Nuvation Bio (Nuvation Bio) Change In Payables And Accrued Expense : $6.50 Mil (TTM As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Change In Payables And Accrued Expense?

Nuvation Bio's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2021 was $3.25 Mil. It means Nuvation Bio's Accounts Payable & Accrued Expense increased by $3.25 Mil from Jun. 2021 to Sep. 2021 .

Nuvation Bio's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2020 was $0.00 Mil. It means Nuvation Bio's Accounts Payable & Accrued Expense stayed the same from . 20 to Dec. 2020 .

Nuvation Bio Change In Payables And Accrued Expense Historical Data

The historical data trend for Nuvation Bio's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Change In Payables And Accrued Expense Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Change In Payables And Accrued Expense
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Change In Payables And Accrued Expense Get a 7-Day Free Trial - 3.24 0.01 3.25 -

Nuvation Bio Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Website
https://www.nuvationbio.com
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.